Aug 21 Update:10 #Bitcoin ETFsNetFlow: -3,600 $BTC(-$408.56M)🔴#iShares(Blackrock) outflows 1,930 $BTC($219.04M) and currently holds 747,424 $BTC($84.81B).9 #Ethereum ETFsNetFlow: -110,161 $ETH(-$471.49M)🔴#iShares(Blackrock) outflows 59,606 $ETH($255.11M) and currently holds 3,486,213 $ETH($14.92B).https://t.co/S3SrESC1ti ...

Core Insights - The iShares Emerging Markets Equity Factor ETF (EMGF) is designed to provide broad exposure to the emerging markets category and was launched on December 8, 2015 [1] - The fund is managed by Blackrock and has accumulated over $939.89 million in assets, making it one of the larger ETFs in the Broad Emerging Market ETFs category [5] - EMGF seeks to match the performance of the MSCI Emerging Markets Diversified Multiple-Factor Index [5] Investment Strategy - Smart beta ETFs, like EMGF, aim to outperform traditional market cap weighted indexes by selecting stocks based on specific fundamental characteristics [3][4] - The fund employs a non-cap weighted strategy to enhance risk-return performance [3] Cost and Performance - EMGF has an annual operating expense ratio of 0.26%, positioning it as one of the cheaper options in the market [7] - The ETF has a 12-month trailing dividend yield of 3.35% [7] - Year-to-date, EMGF has increased by approximately 19.39% and has risen by about 16.63% over the past year [10] Holdings and Diversification - The top 10 holdings of EMGF account for about 25.08% of its total assets, with Taiwan Semiconductor Manufacturing being the largest at approximately 9.65% [8][9] - The ETF holds around 597 stocks, which helps to effectively diversify company-specific risk [11] Alternatives - Other ETFs in the emerging markets space include Vanguard FTSE Emerging Markets ETF (VWO) and iShares Core MSCI Emerging Markets ETF (IEMG), which have significantly larger asset bases of $95.96 billion and $101.31 billion respectively [13] - VWO has a lower expense ratio of 0.07% while IEMG charges 0.09% [13]

Core Insights - The iShares U.S. Medical Devices ETF (IHI) provides broad exposure to the Healthcare - Medical Devices segment and is a passively managed fund launched on May 1, 2006 [1] - The ETF is designed for long-term investors and is favored for its low costs, transparency, flexibility, and tax efficiency [1] Fund Overview - Sponsored by Blackrock, the ETF has over $4.34 billion in assets, making it one of the largest in its category [3] - IHI aims to match the performance of the Dow Jones U.S. Select Medical Equipment Index [3] Cost Structure - The ETF has an annual operating expense ratio of 0.4%, positioning it as a cost-effective option [4] - It offers a 12-month trailing dividend yield of 0.44% [4] Sector Exposure and Holdings - The ETF is fully allocated to the Healthcare sector, with approximately 100% of its portfolio [5] - Abbott Laboratories (ABT) constitutes about 18.79% of total assets, with the top 10 holdings making up approximately 76.07% of total assets [6] Performance Metrics - The ETF has gained about 6.22% year-to-date and 7.89% over the past year as of August 20, 2025 [7] - It has traded between $54.27 and $65.09 in the past 52 weeks, with a beta of 0.88 and a standard deviation of 18.11% over the trailing three-year period [7] Alternatives - The iShares U.S. Medical Devices ETF holds a Zacks ETF Rank of 3 (Hold), indicating a reasonable option for investors [8] - Other alternatives include the First Trust Indxx Medical Devices ETF (MDEV) and the SPDR S&P Health Care Equipment ETF (XHE), with respective assets of $2.04 million and $155.14 million [9]

Group 1: Core Insights - The iShares International Small-Cap Equity Factor ETF (ISCF) debuted on April 28, 2015, providing broad exposure to the Foreign Small/Mid Blend ETF category [1] - The fund is managed by Blackrock and has accumulated over $441.4 million in assets, positioning it as an average-sized ETF in its category [5] - The fund aims to match the performance of the MSCI World exUSA Small Cap Diversified Multiple-Factor Index [5] Group 2: Fund Characteristics - The annual operating expenses for ISCF are 0.23%, making it one of the cheaper options in the market [7] - The fund has a 12-month trailing dividend yield of 3.94% [7] - The top 10 holdings account for approximately 5.56% of total assets under management, with Banco De Sabadell Sa being the largest holding at 0.83% [8][9] Group 3: Performance Metrics - As of August 19, 2025, ISCF has gained about 26.71% year-to-date and approximately 25.28% over the last year [10] - The fund has traded between $30.25 and $40.15 during the past 52 weeks [10] - ISCF has a beta of 0.82 and a standard deviation of 16.30% over the trailing three-year period, indicating a medium risk profile [11] Group 4: Alternatives and Market Context - ISCF is a viable option for investors looking to outperform the Foreign Small/Mid Blend ETF segment, but there are alternative ETFs available [12] - Other ETFs in the space include SPDR S&P International Small Cap ETF (GWX) with $758.52 million in assets and Schwab International Small-Cap Equity ETF (SCHC) with $4.75 billion [13] - GWX has an expense ratio of 0.40%, while SCHC has a lower expense ratio of 0.08% [13]

Core Insights - The iShares U.S. Energy ETF (IYE) is a passively managed ETF launched on June 12, 2000, designed to provide broad exposure to the Energy - Broad segment of the equity market [1] - The ETF has amassed over $1.15 billion in assets, making it one of the largest ETFs in the Energy sector [3] - The ETF has a low expense ratio of 0.39% and a 12-month trailing dividend yield of 2.84% [4] Index and Performance - IYE seeks to match the performance of the Dow Jones U.S. Oil & Gas Index and has a beta of 0.81, indicating lower volatility compared to the market [3][7] - The ETF has gained approximately 0.86% year-to-date but is down about 2.27% over the past year, with a trading range between $40.36 and $51.38 in the last 52 weeks [7] Sector Exposure and Holdings - The ETF has a heavy allocation in the Energy sector, with about 98.5% of its portfolio dedicated to this sector [5] - Exxon Mobil Corp (XOM) is the largest holding, accounting for approximately 22.39% of total assets, followed by Chevron Corp (CVX) and Conocophillips (COP) [6] Alternatives and Comparisons - The iShares U.S. Energy ETF carries a Zacks ETF Rank of 3 (Hold), indicating a sufficient option for investors seeking exposure to the Energy ETFs area [8] - Other alternatives include the Vanguard Energy ETF (VDE) and the Energy Select Sector SPDR ETF (XLE), with VDE having $6.98 billion in assets and XLE having $26.13 billion [9]

Crypto ETF Flows - Bitcoin ETFs saw net inflows of 722 BTC, equivalent to $83480000 [1] - Ethereum ETFs experienced net inflows of 25218 ETH, totaling $109470000 [1] Bitcoin ETF Holdings - iShares (Blackrock) Bitcoin ETF inflows amounted to 976 BTC, valued at $112860000 [1] - iShares (Blackrock) currently holds 749945 BTC, with a total value of $86670000000 [1] Ethereum ETF Holdings - iShares (Blackrock) Ethereum ETF inflows reached 76851 ETH, worth $333610000 [1] - iShares (Blackrock) currently holds 3567302 ETH, with a total value of $15490000000 [1]

Core Insights - The iShares Biotechnology ETF (IBB) is a smart beta ETF that provides broad exposure to the Health Care ETFs category, having debuted on February 5, 2001 [1] - Smart beta ETFs are designed to outperform traditional market cap weighted indexes by focusing on specific fundamental characteristics [3][4] - IBB is managed by Blackrock and has over $5.63 billion in assets, making it one of the largest ETFs in the Health Care sector [5] Fund Details - IBB aims to match the performance of the Nasdaq Biotechnology Index, which includes securities of NASDAQ listed biotechnology and pharmaceutical companies [5] - The fund has an annual operating expense of 0.45% and a 12-month trailing dividend yield of 0.28% [6] - The fund's portfolio is entirely allocated to the Healthcare sector, with Vertex Pharmaceuticals Inc (VRTX) being the largest holding at approximately 7.96% of total assets [7][8] Performance Metrics - As of August 18, 2025, IBB has returned approximately 5.05% year-to-date but is down about -4.01% over the past year [10] - The fund has traded between $112.02 and $149.47 in the last 52 weeks, with a beta of 0.75 and a standard deviation of 20.16% over the trailing three-year period, indicating a higher risk profile [10] Alternatives - Other ETFs in the biotechnology space include the First Trust NYSE Arca Biotechnology ETF (FBT) and the SPDR S&P Biotech ETF (XBI), with assets of $1.08 billion and $5.09 billion respectively [12] - FBT has an expense ratio of 0.54% while XBI charges 0.35%, presenting lower-cost alternatives for investors [12]

THIS IS MASSIVE FOR $ETH !!🇺🇸 The U.S. SPOT Ethereum ETFs bought a record $2.85 billion worth of Ethereum this week, marking the largest weekly inflow ever. Blackrock alone bought $2.32 billion ETHThese guys 100% know something https://t.co/sryFt1EGmR ...

Market Dynamics - Blackrock is consuming 52 days of ETH issuance every 24 hours, indicating strong demand [1] - Blackrock's demand is 52 times the ETH issuance rate, breaking resistance levels [1] ETH Foundation Activity - ETH Foundation sold 4,095 ETH into Blackrock's $520 million buys [1] Investor Behavior - Smart money may be front-running dumb money [1] Supply and Demand - Exit queue locked at 744 thousand ETH [1]

Crypto ETF Flows - Bitcoin ETFs saw a net inflow of 1,738 BTC, equivalent to $205170000 [1] - Ethereum ETFs experienced a net inflow of 138,232 ETH, totaling $629780000 [1] BlackRock's iShares Holdings - iShares Bitcoin ETF inflows amounted to 4,428 BTC, valued at $522680000 [1] - iShares currently holds 748,968 BTC, with a total value of $88400000000 (884 billion) [1] - iShares Ethereum ETF inflows reached 114,069 ETH, worth $519700000 [1] - iShares' Ethereum holdings stand at 3,490,451 ETH, valued at $15900000000 (159 billion) [1]